{"database": "lobbying", "table": "lobbying_activities", "rows": [[2179368, "dd0efeee-7b2c-4c76-b04c-3a79e992d353", "3A", "OTT BIELITZKI & O'NEILL PLLC", 401103584, "BODYSTREET GMBH", 2018, "third_quarter", "CSP", "Working with FDA to ensure company uses only FDA-approved EMS technology.", "Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE", 7000, null, 0, 0, "2018-10-01T21:09:36.493000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2179368"], "units": {}, "query_ms": 11.410854989662766, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}